Defending the con side: Obesity paradox does not exist

Diabetes Care

Volumn 36, Issue SUPPL.2, 2013, Pages

  Standl, Eberhard ^a   Erbach, Michael ^a   Schnell, Oliver ^a  

^a Helmholtz Centre   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NATEGLINIDE; VALSARTAN;

ANABOLIC DEFICIENCY; BARIATRIC SURGERY; BODY MASS; CACHEXIA; CARDIAC CACHEXIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; DISEASE ASSOCIATION; HEALTH CARE DISPARITY; HEART DISEASE; HUMAN; LIFESTYLE MODIFICATION; METABOLIC DISORDER; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHENOTYPE; PRACTICE GUIDELINE; REVIEW; RISK REDUCTION; SELECTION BIAS; SMOKING; TREATMENT BIAS; WEIGHT CHANGE; WEIGHT REDUCTION;

HUMANS; OBESITY;

EID: 84890510306     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dcS13-2040     Document Type: Review

References (38)

1. Hainer V, Aldhoon-Hainerova I. Obesity paradox does exist. Diabetes Care 2013; 36(Suppl. 2):S276-S281
2. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359:2105-2120
3. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-1209
4. Shimazu T, Kuriyama S, Ohmori-Matsuda K, Kikuchi N, Nakaya N, Tsuji I. Increase in body mass index category since age 20 years and all-cause mortality: a prospective cohort study (the Ohsaki Study). Int J Obes (Lond) 2009;33:490-496
5. World Health Organization. Global status report on noncommunicable diseases. Chapter 1. Burden: mortality, morbidity and risk factors [article online], 2010. Available from http://www.who.int/nmh/publications/ncd-report- full-en.pdf. Accessed 25 September 2012
6. Yan LL, Daviglus ML, Liu K, et al. Midlife body mass index and hospitalization and mortality in older age. JAMA 2006;295: 190-198
7. Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13, 087 patients. Dia-betologia 2009;52:65-73
8. Strazzullo P, D'Elia L, Cairella G, Garbagnati F, Cappuccio FP, Scalfi L. Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke 2010;41:e418-e426
9. Karasoy D, Gislason G, Torp-Pedersen C, et al. Obesity is a powerful predictor of atrial fibrillation in fertile women. Abstract presented at the European Society of Cardiology Congress, 25-29 August 2012, Munich, Germany
10. Holman RR, Haffner SM, McMurray JJ, et al.; NAVIGATOR Study Group. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med 2010;362:1463-1476
11. Sugawara A, Kawai K, Motohashi S, et al. HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2. Dia-betologia 2012;55:2128-2131
12. Florez H, Castillo-Florez S. Beyond the obesity paradox in diabetes: fitness, fatness, and mortality. JAMA 2012;308:619-620
13. Alwan A, Maclean DR, Riley LM, et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet 2010;376:1861-1868
14. Schernthaner G, Brix JM, Kopp HP, Schernthaner GH. Cure of type 2 diabetes by metabolic surgery? A critical analysis of the evidence in 2010. Diabetes Care 2011; 34(Suppl. 2):S355-S360
15. Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011;34:210-215
16. von Haehling S, Hartmann O, Anker SD. Does obesity make it better or worse: insights into cardiovascular illnesses. Eur Heart J 2013;34:330-332
17. Angerås O, Albertsson P, Karason K, et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J 2013;34:345-353
18. Logue J, Murray HM, Welsh P, et al. Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation. Heart 2011; 97:564-568
19. Stamler J, Rhomberg P, Schoenberger JA, et al. Multivariate analysis of the relationship of seven variables to blood pressure: findings of the Chicago Heart Association Detection Project in Industry, 1967-1972. J Chronic Dis 1975;28:527-548
20. Anselmino M, Bartnik M, Malmberg K, Rydén L; Euro Heart Survey Investigators. Management of coronary artery disease in patients with and without diabetes melli-tus. Acute management reasonable but secondary prevention unacceptably poor: a report from the Euro Heart Survey on Diabetes and the Heart. Eur J Cardiovasc Prev Rehabil 2007;14:28-36
21. Eliasson B, Cederholm J, Nilsson P, Gudbjörnsdóttir S; Steering Committee of the Swedish National Diabetes Register. The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003. Diabet Med 2005; 22:1420-1426
22. Stiegler H, Standl E, Frank S, Mendler G. Failure of reducing lower extremity amputations in diabetic patients: results of two subsequent population based surveys 1990 and 1995 in Germany. Vasa 1998; 27:10-14
23. Rutter MK. Low HbA1c and mortality: causation and confounding. Diabetologia 2012;55:2307-2311
24. Artero EG, Lee DC, Ruiz JR, et al. A prospective study of muscular strength and all-cause mortality in men with hypertension. J Am Coll Cardiol 2011;57: 1831-1837
25. Welsh P, McMurray JJ. B-type natriuretic peptide and glycaemia: an emerging car-diometabolic pathway? Diabetologia 2012; 55:1240-1243
26. Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012;55:2319-2326
27. Ang DS, Welsh P, Watt P, Nelson SM, Struthers A, Sattar N. Serial changes in adiponectin and BNP in ACS patients: paradoxical associations with each other and with prognosis. Clin Sci (Lond) 2009; 117:41-48
28. Schnabel R, Messow CM, Lubos E, et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J 2008;29:649-657
29. Ortega FB, Lee DC, Katzmarzyk PT, et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013; 34:389-397
30. Sierra-Johnson J, Romero-Corral A, Somers VK, et al. Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil 2008;15:336-340
31. Wing RR, Lang W, Wadden TA, et al.; Look AHEAD Research Group. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 2011;34:1481-1486
32. Hardoon SL, Morris RW, Whincup PH, et al. Rising adiposity curbing decline in the incidence of myocardial infarction: 20-year follow-up of British men and women in the Whitehall II cohort. Eur Heart J 2012;33:478-485
33. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008;371:1783-1789
34. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012;307: 56-65
35. Sjöström L, Narbro K, Sjöström CD, et al.; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007;357: 741-752
36. Sjöström L, Gummesson A, Sjöström CD, et al.; Swedish Obese Subjects Study. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 2009;10:653-662
37. Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012;367:695-704
38. McMurray JJ, Adamopoulos S, Anker SD, et al.; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-1847